tiprankstipranks
Trending News
More News >
Acuren Corporation (TIC)
:TIC
US Market
Advertisement

Acuren Corporation (TIC) AI Stock Analysis

Compare
2 Followers

Top Page

TIC

Acuren Corporation

(NYSE:TIC)

Rating:66Neutral
Price Target:
$12.00
▲(1.61%Upside)
Acuren Corporation's stock score is driven by a challenging financial performance and valuation uncertainty, offset by positive technical trends and a strategic merger with NV5 Global. The merger is a significant factor, expected to enhance future growth and stockholder value.

Acuren Corporation (TIC) vs. SPDR S&P 500 ETF (SPY)

Acuren Corporation Business Overview & Revenue Model

Company DescriptionAcuren Corporation (TIC) is a leading provider of nondestructive testing (NDT), inspection, and engineering services primarily to the energy, mining, infrastructure, and defense sectors. The company specializes in ensuring the structural integrity and reliability of critical industrial assets through advanced testing and inspection techniques. Acuren's core services include ultrasonic testing, radiographic testing, magnetic particle testing, and visual inspection, among others, catering to a wide range of industrial applications.
How the Company Makes MoneyAcuren Corporation generates revenue through a combination of service fees for its testing, inspection, and engineering services. The company's key revenue streams include contracts with clients in industries such as oil and gas, power generation, and mining, where the maintenance of infrastructure is critical. Acuren often enters into long-term service agreements with major industrial clients, providing consistent cash flow. Additionally, the company leverages its expertise and advanced technology solutions to offer specialized services, enhancing its value proposition and revenue potential. Partnerships with technology providers and ongoing innovation in service delivery further support Acuren's revenue model, allowing it to meet the evolving needs of its client base effectively.

Acuren Corporation Financial Statement Overview

Summary
Acuren Corporation is facing challenges with declining revenues and profitability issues. The balance sheet shows a strong equity base, but liquidity challenges exist, necessitating improved revenue generation and cost management strategies.
Income Statement
55
Neutral
Acuren Corporation has seen a significant drop in revenue from the previous year, translating to a negative revenue growth rate. The gross profit margin stands at 25.55%, indicating moderate efficiency in controlling production costs. However, the company is facing challenges with profitability, as evidenced by a negative net profit margin of -2.48% and a significant decline in EBIT and EBITDA margins to 5.59%. This highlights the need for improved cost management and revenue generation strategies.
Balance Sheet
70
Positive
The balance sheet reveals a strong equity position with an equity ratio of 52.15%, indicating stability and a solid asset base. However, the debt-to-equity ratio is 0.71, suggesting moderate leverage which could pose a risk if not managed carefully. The return on equity is negative at -1.36%, reflecting the current struggles with profitability.
Cash Flow
40
Negative
The cash flow statement shows declining free cash flow, with a negative free cash flow growth rate, indicating liquidity challenges. The operating cash flow to net income ratio is 0.17, suggesting inefficiencies in converting revenue into cash. The free cash flow to net income ratio is negative due to negative free cash flow, necessitating a focus on cash management and operational efficiencies.
BreakdownDec 2024Dec 2023
Income Statement
Total Revenue633.87M1.05B
Gross Profit161.99M239.52M
EBITDA35.41M150.56M
Net Income-15.70M-6.29M
Balance Sheet
Total Assets2.21B1.26B
Cash, Cash Equivalents and Short-Term Investments139.13M87.06M
Total Debt812.58M730.00M
Total Liabilities1.06B880.62M
Stockholders Equity1.15B382.00M
Cash Flow
Free Cash Flow-10.61M73.67M
Operating Cash Flow2.63M95.81M
Investing Cash Flow-1.83B-26.53M
Financing Cash Flow1.41B-49.18M

Acuren Corporation Technical Analysis

Technical Analysis Sentiment
Positive
Last Price11.81
Price Trends
50DMA
11.01
Positive
100DMA
10.84
Positive
200DMA
10.89
Positive
Market Momentum
MACD
0.27
Negative
RSI
60.99
Neutral
STOCH
68.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TIC, the sentiment is Positive. The current price of 11.81 is above the 20-day moving average (MA) of 11.44, above the 50-day MA of 11.01, and above the 200-day MA of 10.89, indicating a bullish trend. The MACD of 0.27 indicates Negative momentum. The RSI at 60.99 is Neutral, neither overbought nor oversold. The STOCH value of 68.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TIC.

Acuren Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$1.49B19.8415.06%1.05%9.46%5.91%
71
Outperform
$1.53B22.9911.04%1.42%1.35%-40.63%
69
Neutral
$1.37B35.9913.07%1.08%10.06%-7.56%
68
Neutral
$1.34B38.525.25%3.02%95.76%
67
Neutral
£2.85B10.424.69%215.06%2.73%-20.56%
66
Neutral
$1.43B3.24
53
Neutral
$1.43B-43.18%167.99%22.75%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TIC
Acuren Corporation
11.94
1.79
17.64%
DCO
Ducommun
88.69
25.82
41.07%
LNN
Lindsay
137.49
15.46
12.67%
TNC
Tennant Co
82.09
-24.66
-23.10%
EH
Ehang Holdings
19.90
7.48
60.23%
CDRE
Cadre Holdings
33.70
-2.82
-7.72%

Acuren Corporation Corporate Events

M&A TransactionsBusiness Operations and StrategyFinancial Disclosures
Acuren Corporation to Present at Baird Conference
Neutral
Jun 3, 2025

On June 3, 2025, Acuren Corporation held investor presentations and is scheduled to present at the Baird 2025 Global Consumer, Technology & Services Conference on June 4, 2025. The company discussed its business combination with NV5, highlighting potential synergies, financial performance, and strategic advantages. However, the announcement also noted various risks and uncertainties that could impact future performance, including economic conditions, regulatory changes, and geopolitical risks.

The most recent analyst rating on (TIC) stock is a Hold with a $11.50 price target. To see the full list of analyst forecasts on Acuren Corporation stock, see the TIC Stock Forecast page.

Delistings and Listing ChangesBusiness Operations and StrategyFinancial Disclosures
Acuren Corporation Announces NYSE Listing Transfer
Neutral
May 15, 2025

On May 13, 2025, Acuren Corporation‘s Board of Directors approved the voluntary delisting of its common stock from the NYSE American to transfer its listing to the New York Stock Exchange, effective May 19, 2025. This strategic move is expected to enhance the company’s market presence and operational flexibility. In the first quarter of 2025, Acuren reported a revenue increase of 5.0% to $234.2 million, driven by strong organic growth and service line expansion. Despite a net loss of $25.9 million due to increased depreciation and acquisition-related costs, the company demonstrated resilience with a 7.2% organic growth and solid cash flow, maintaining its full-year outlook for sustainable growth and shareholder value enhancement.

M&A Transactions
Acuren Corporation Announces Merger with NV5 Global
Positive
May 15, 2025

On May 14, 2025, Acuren Corporation and NV5 Global, Inc. announced a merger agreement to create a leading global Testing, Inspection, Certification, and Compliance (TICC) and engineering services firm with a combined revenue of $2 billion. The merger is expected to be immediately accretive to Acuren stockholders and includes approximately $20 million in cost synergies. NV5 stockholders will receive $23.00 per share, representing a 32% premium to NV5’s 30-day VWAP as of May 14, 2025. The transaction is subject to approval by stockholders of both companies and regulatory approvals, with an expected closing in the second half of 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 01, 2025